Does GRANISETRON Cause Malignant neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with GRANISETRON (Granisetron Hydrochloride). This represents 0.3% of all adverse event reports for GRANISETRON.
8
Reports of Malignant neoplasm progression with GRANISETRON
0.3%
of all GRANISETRON reports
4
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From GRANISETRON?
Of the 8 reports, 4 (50.0%) resulted in death, 1 (12.5%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GRANISETRON. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does GRANISETRON Cause?
Nausea (433)
Product adhesion issue (395)
Death (319)
Vomiting (185)
Drug ineffective (177)
Wrong technique in product usage process (172)
Constipation (129)
Inappropriate schedule of drug administration (115)
No adverse event (111)
Product use in unapproved indication (103)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which GRANISETRON Alternatives Have Lower Malignant neoplasm progression Risk?
GRANISETRON vs GRANULOCYTE COLONY-STIMULATING FACTOR NOS
GRANISETRON vs GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
GRANISETRON vs GRAZOPREVIR
GRANISETRON vs GRISEOFULVIN
GRANISETRON vs GUAIFENESIN